In the microimmunofluorescence test for measuring immunoglobulin A (IgA) antibodies against Chlamydia pneumoniae, removal of interfering IgG antibodies made IgA antibody reactivity patterns in 952 serum samples easier to interpret, prozone effects disappeared, and titers increased, especially in the sera with high IgG titers.
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IgA rheumatoid factors did not interfere in the assay.
Elevated or persisting titers of specific immunoglobulin A (IgA) antibodies have been suggested to be markers of chronic bacterial infections in yersinial reactive arthritis (4) , in cystic fibrosis pulmonary infections caused by Pseudomonas aeruginosa (1, 5) , and in chronic pelvic inflammatory disease caused by Chiamydia trachomatis (3, 9) . Recently, chronic Chlamydia pneumoniae infection has been associated with coronary heart disease (7), and specific elevated IgA antibody titers were suggested to be better markers of chronic infection than respective IgG titers (8) .
IgA titers in the microimmunofluorescence (micro-IF) test (12) are often difficult to read. There is a marked tendency to prozone effect, and the fluorescence pattern is often much weaker than in IgG titrations. This phenomenon, also seen in IgM titrations by this test, has been related to interfering IgG antibodies of higher affinity (6) . A similar effect on IgA titrations in enzyme immunoassay (EIA) has also been found (2) . Moreover, IgM rheumatoid factors (IgM-RFs) are known to lead to false-positive IgM findings (11) , and positive IgM titers should always be verified after the removal or inactivation of IgG antibodies. In this study we studied the effect of IgG removal on IgA antibody titers to C. pneumoniae in the micro-IF test.
Altogether, 952 serum samples from Jewish residents of Jerusalem aged 25 to 64 were studied. One-third of the sera were obtained from cases of first myocardial infarction during their hospitalization, and the remainder were obtained from an age-weighted control group representative of Jerusalem residents. The male to female ratio was about 2:1. Chlamydial serum IgG and IgA antibodies were determined by the micro-IF test (13) . For IgA antibody measurements, all sera were at first titrated untreated and then after treatment with Gull-SORB (Gull Laboratories, Salt Lake City, Utah) according to the instructions of the producer to remove The presence of IgA-RF was tested by EIA (10) . Human IgG, Fc fraction (Jackson), 2.5 ,ug/ml in carbonate buffer, pH 9.6, was used as coating antigen. EIA plates were postcoated with 1% human serum albumin by incubation for 30 min at room temperature. Sera were diluted 1:20 with phosphate buffer, pH 7.2, containing 0.05% Tween, 0.2% human serum albumin, and 4% polyethylene glycol. Alkaline phosphatase conjugated F(ab')2 fragments of rabbit anti-human IgA (Jackson) were used in a dilution of 1:3,000. Sera and conjugate were incubated for 1 h at room temperature, andp-nitrophenyl phosphate (Sigma) was used as a substrate.
The prevalences of positive IgA (-10) and IgG (.16) antibody titers to C. pneumoniae were high in serum samples, 52.7 and 79.3% respectively, and geometric mean titers were 37 and 156. Removal of IgG antibodies made IgA titrations easier to read; fluorescence was brighter and more clearcut, and prozone effect disappeared. In most cases there were no changes in IgA titer after treatment with GullSORB, and two IgA titers correlated well (r = 0.83, P < 0.01). However, 85 (8.9%) of 952 samples showed marked (fourfold or more) change in titer, and this correlated to high IgG titers in the sera (Tables 1 and 2 ).
All of the 28 sera with decreasing titer and, as a control, 10 with increasing titer after IgG inactivation were tested by 
